This information was published on 2026-03-12T05:15:39 for IP Right Filed Published.
| Field | Value |
| (210) | 2634619 (IR 1907099) |
| (220) |
04 Feb 2026
|
| (300) |
JM, 07 Aug 2025, 95511
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders. |
| (540) | ZABALA |
| (550) | Word |
| (730) |
Amylyx Pharmaceuticals, Inc.
|
Find out more about publications on the About page.